Saria R. Dbar

Moscow, MOW 111123, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Justification for the use of a FODMAP diet in patients with irritable bowel syndrome: focus on small intestinal disaccharidase activity

Justification for the use of a FODMAP diet in patients with irritable bowel syndrome: focus on small intestinal disaccharidase activity

Journal: Terapevticheskii arkhiv

Published: July 03, 2025

Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome

Visceral sensitivity in diagnostics and treatment of severe irritated bowel syndrome

Journal: Terapevticheskii arkhiv

Published: September 05, 2022

The effect of the FODMAP and rebamipid diet on the activity of disaccharidases in patients with enteropathy with impaired membrane digestion

The effect of the FODMAP and rebamipid diet on the activity of disaccharidases in patients with enteropathy with impaired membrane digestion

Journal: Terapevticheskii arkhiv

Published: April 14, 2022

Celiac crisis in patients with celiac disease. Case report

Celiac crisis in patients with celiac disease. Case report

Journal: Terapevticheskii arkhiv

Published: August 15, 2021

COVID-19 and the small intestine

COVID-19 and the small intestine

Journal: Terapevticheskii arkhiv

Published: March 15, 2021

Enteropathy with impaired membrane digestion and the prospects for cytoprotective therapy

Enteropathy with impaired membrane digestion and the prospects for cytoprotective therapy

Journal: Terapevticheskii arkhiv

Published: February 15, 2021

Patients with functional bowel disorder have disaccharidase deficiency: A single-center study from Russia.

Patients with functional bowel disorder have disaccharidase deficiency: A single-center study from Russia.

Journal: World journal of clinical cases

Published: January 09, 2021

Rebamipide increases the disaccharidases activity in patients with enteropathy with impaired membrane digestion. Pilot study.

Rebamipide increases the disaccharidases activity in patients with enteropathy with impaired membrane digestion. Pilot study.

Journal: Terapevticheskii arkhiv

Published: May 17, 2019

Showing 1-8 of 8

Last Updated: 09/26/2026